FLT3 mutations for targeted therapy in AML

############################# Video Source: www.youtube.com/watch?v=4QiYbxMazXo

In the last 15 years, there has been a revolution in our understanding of the pathogenesis of acute myeloid lymphoma (AML), as new genetic mutations have bee...

Speaker: Amir Fathi, Event: SOHO 2018, Format: Interview, Subject: Leukemia, Subject: Acute Myeloid Leukemia, Fields: Treatment, Medicines: Midostaurin, FLT3, P53, combination therapy, chemotherapy, targeted therapy, relapse, refractory, frontline therapy
#############################